Contact

Blue Shift Home About Services Contact Brain-health questions, clearly held Ibogaine for Hockey An explainer on a controversial psychedelic therapy crossing from veteran medicine into the rink: what it is, why players are curious, and how safety, anti-doping, and law shape decisions. Blue Shift Updated July 2026 Choices around health, eligibility, and recovery require more than a single hopeful story. Across professional and amateur hockey, a small but vocal group of athletes is talking about ibogaine as a possible off-ramp from persistent symptoms linked to head trauma, mood disorders, and substance problems that can trail a hard career on the ice. The conversation grew louder as stories migrated from training rooms to policy rooms, with state commitments such as the Texas ibogaine initiative signaling a shift from stigma to research funding and drug development pathways that could eventually change practice. Even in ice hockey circles, the term evokes equal parts hope and caution: hope for relief from concussion-related fog, chronic pain, depression, anxiety, or opioid use disorder; caution because this psychoactive alkaloid carries meaningful cardiac risks and sits in a complex legal and anti-doping landscape. What follows is a plain-spoken, evidence-tethered tour of pharmacology, study safety protocols, governance rules, and realistic alternatives for pain management and mental health when the risks outweigh potential gains. Start with uncertainty Blue Shift is an independent resource for hockey players, former players, families, and supporters seeking careful context on concussion-related concerns, mental health, substance use, and unanswered questions. 01 / orientation what ibogaine is and why athletes are talking about it The interest is real, but it does not turn an investigational substance into a proven treatment or a safe self-directed option. Ibogaine is a psychoactive alkaloid derived from Tabernanthe iboga. In the body it is metabolized primarily by CY

Contact

Published channels